Carboquone
Chemical compound
- L01AC03 (WHO)
- {2-[2,5-bis(aziridin-1-yl)-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-2-methoxyethyl} carbamate
- 24279-91-2
- 2569
- 2471
- 1CB0HBT12C
- ChEMBL443014
- DTXSID8046870
- Interactive image
- O=C(OCC(OC)C=1C(=O)\C(=C(/C(=O)C=1N2CC2)C)N3CC3)N
InChI
- InChI=1S/C15H19N3O5/c1-8-11(17-3-4-17)14(20)10(9(22-2)7-23-15(16)21)12(13(8)19)18-5-6-18/h9H,3-7H2,1-2H3,(H2,16,21)
- Key:SHHKQEUPHAENFK-UHFFFAOYSA-N
Carboquone is a drug used in chemotherapy.[1]
References
- ^ Saito T (March 1988). "[An anticancer drug--carboquone]" [An anticancer drug--carboquone]. Gan to Kagaku Ryoho. Cancer & Chemotherapy (in Japanese). 15 (3): 549–54. PMID 3279914.
See also
- Chemotherapy
- Aziridine
- v
- t
- e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
(M phase)
Block microtubule assembly | |
---|---|
Block microtubule disassembly |
inhibitor
DNA precursors/ antimetabolites (S phase) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Topoisomerase inhibitors (S phase) |
| ||||||||
Crosslinking of DNA (CCNS) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e